Pharmaceuticals, health and wellness

AbbVie touts Qulipta chronic migraine win as Biohaven duel heats up aliu Thu, 03/10/2022 – 10:34 Source link

Pfizer is halting investment in Russia but not ending its business there. Should drugmakers pull out altogether? kdunleavy Thu, 03/10/2022 – 09:28 Source link

Novartis puts contract manufacturing ambitions on display with deal to produce Carisma’s cell therapy fkansteiner Thu, 03/10/2022 – 09:16 Source link

Gilead to boost West Coast production muscle after revealing New Jersey layoffs fkansteiner Thu, 03/10/2022 – 07:57 Source link

Moderna CEO’s pay jumps 41% to $18.2M as COVID vaccine giant expands globally aliu Thu, 03/10/2022 – 05:24 Source link

With FDA AdComm on the books, Acadia sees glimmer of hope in second stab at Alzheimer’s psychosis aliu Wed, 03/09/2022 – 11:14 Source link

J&J inks vaccine licensing deal with Aspen, paving the way for Africa’s first local COVID-19 shot fkansteiner Wed, 03/09/2022 – 10:40 Source link

India’s hesitance to condemn Russia puts the country’s pharma industry in compromising position kdunleavy Wed, 03/09/2022 – 09:43 Source link

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year fkansteiner Wed, 03/09/2022 – 09:30 Source link

That key Gilead breast cancer readout? Try 2024, and don’t get your hopes up: analyst aliu Wed, 03/09/2022 – 09:26 Source link

Mallinckrodt inks $260M settlement with US to resolve Medicaid underpayment and kickbacks allegations kdunleavy Tue, 03/08/2022 – 16:52 Source link

Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA fkansteiner Tue, 03/08/2022 – 15:05 Source link